Meridian Bioscience: Fiscal 3Q Earnings Snapshot

Associated Press
Updated ·1 min read

CINCINNATI (AP) _ Meridian Bioscience Inc. (VIVO) on Friday reported fiscal third-quarter profit of $27.5 million.

The Cincinnati-based company said it had net income of 64 cents per share. Earnings, adjusted for one-time gains and costs, were 55 cents per share.

The diagnostic test maker posted revenue of $84.8 million in the period.

Meridian Bioscience expects full-year earnings in the range of $1.01 to $1.05 per share, with revenue in the range of $245 million to $250 million.

Meridian Bioscience shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VIVO at https://www.zacks.com/ap/VIVO